4//SEC Filing
Lewicki John A. 4
Accession 0001140361-18-009950
CIK 0001302573other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:39 PM ET
Size
5.4 KB
Accession
0001140361-18-009950
Insider Transaction Report
Form 4
Lewicki John A.
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-02-21+125,000→ 125,000 totalExercise: $2.23Exp: 2028-02-20→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 31, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeother
Related Parties
1- filerCIK 0001553352
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 6:39 PM ET
- Size
- 5.4 KB